Abstract | BACKGROUND:
Olanexidine gluconate (OLG) is a newly developed skin antiseptic, which is effective against a broad range of bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. The purpose of this study was to evaluate the bactericidal efficacy and safety of OLG in orthopaedic surgery. METHODS: This retrospective study included a total of 1103 patients who underwent clean orthopaedic surgery. They were divided into two groups: 556 patients who were treated with OLG (OLG group), and 547 patients who were treated with povidone-iodine ( PVP-I) ( PVP-I group). The efficacy and the safety outcomes were measured as the rate of surgical-site infection (SSI) within 30 days after surgery and the rate of adverse skin reaction, respectively. RESULTS: There was no significant difference between the OLG group and PVP-I group (1.80% vs. 2.38%; p = 0.50) based on the overall rate of SSI. Also, there was no significant difference in both superficial incisional infections (1.08% vs. 2.01%; p = 0.21) and deep incisional infections (0.72% vs. 0.37%; p = 0.35). The overall rate of adverse skin reaction was significantly higher in the OLG group than in the PVP-I group (2.16% vs. 0.73%; p = 0.047). CONCLUSIONS: This retrospective study demonstrated that OLG has an efficacy similar to PVP-I in preventing SSI in clean orthopaedic surgery. However, adverse skin reactions at the application site of OLG requires more attention.
|
Authors | Mitsuru Asukai, Tsuyoshi Ohishi, Tomotada Fujita, Daisuke Suzuki, Tatsuya Nishida, Kaori Sugiura, Yukihiro Matsuyama |
Journal | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
(J Orthop Sci)
Vol. 24
Issue 6
Pg. 1125-1129
(Nov 2019)
ISSN: 1436-2023 [Electronic] Japan |
PMID | 31395421
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2019. Published by Elsevier B.V. |
Chemical References |
- Anti-Infective Agents, Local
- Biguanides
- Glucuronates
- Povidone-Iodine
- olanexidine gluconate
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Anti-Infective Agents, Local
(therapeutic use)
- Biguanides
(therapeutic use)
- Female
- Glucuronates
(therapeutic use)
- Humans
- Male
- Middle Aged
- Orthopedic Procedures
- Povidone-Iodine
(therapeutic use)
- Retrospective Studies
- Surgical Wound Infection
(microbiology, prevention & control)
|